Faculty Publications
As of August 2017, this database is no longer being updated. For the most current publications from the faculty, students, and staff of Touro University, please check our institutional repository, Touro Scholar, and email any questions or publication submissions to touro.scholar@touro.edu.
Total number of publications: 7,082
Enter a faculty name:
or browse faculty by school:
Administrative Offices
Graduate Schools
Health Sciences
Lander Colleges
Law Center
New York School of Career and Applied Studies (NYSCAS)
Touro University System
New York Medical College (NYMC)
Touro University California
Touro University Nevada
Citrome, L. (2015). My two favourite professional social networking sites: LinkedIn and ResearchGate - how they can help you, or hurt you. International Journal of Clinical Practice, 69(6), 623-624. doi:10.1111/ijcp.12681
Citrome, L. (2015). Partial and non-adherence: We need all the help we can get. International Journal of Clinical Practice, 69(1), 1-2. doi:10.1111/ijcp.12610
Citrome, L. (2015). The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(11), 1211-1220. doi:10.1111/ijcp.12752
Citrome, L. (2015). Transdermal patches: How common are application site reactions and how severe are they? International Journal of Clinical Practice, 69(5), 509-510. doi:10.1111/ijcp.12668
Citrome, L. (2015). Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: The 15-min challenge to sort these agents out. International Journal of Clinical Practice, 69(2), 151-155. doi:10.1111/ijcp.12620
Citrome, L. (2015). What is good publication practice, what is ISMPP, and why you should care. International Journal of Clinical Practice, 69(9), 913-914. doi:10.1111/ijcp.12725
Citrome, L. (2016). Aripiprazole long-acting injectable formulations for schizophrenia: Aripiprazole monohydrate and aripiprazole lauroxil. Expert Review of Clinical Pharmacology, 9(2), 169-186. doi:10.1586/17512433.2016.1121809
Citrome, L. (2016). Breakthrough drugs for the interface between psychiatry and neurology. International Journal of Clinical Practice, 70(4), 298-299. doi:10.1111/ijcp.12805
Citrome, L. (2016). Cariprazine for the treatment of schizophrenia: A review of this dopamine D3-preferring D3/D2 receptor partial agonist. Clinical Schizophrenia & Related Psychoses, 10(2), 109-119. doi:10.3371/1935-1232-10.2.109
Citrome, L. (2016). Emerging pharmacological therapies in schizophrenia: What's new, what's different, what's next? CNS Spectrums, 21(S1), 1-12. doi:10.1017/S1092852916000729
Citrome, L. (2016). Food for thought: Do you ask about eating? International Journal of Clinical Practice, 70(7), 516-517. doi:10.1111/ijcp.12845
Citrome, L. (2016). From banknotes to people: One million is impressive. International Journal of Clinical Practice, 70(9), 702-703. doi:10.1111/ijcp.12875
Citrome, L. (2016). How do I get my manuscript accepted? Steps and missteps. International Journal of Clinical Practice, 70(2), 97-98. doi:10.1111/ijcp.12782
Citrome, L. (2016). More food for thought: Preferred words. International Journal of Clinical Practice, 70(8), 640. doi:10.1111/ijcp.12865
Citrome, L. (2016). Open researcher and contributor ID: ORCID now mandatory for Wiley journals. International Journal of Clinical Practice, 70(11), 884-885. doi:10.1111/ijcp.12912
Citrome, L. (2016). Peer review and Publons - enhancements for the reviewer. International Journal of Clinical Practice, 70(5), 364. doi:10.1111/ijcp.12827
Citrome, L. (2016). Perceptions matter: Attitudes and health outcomes. International Journal of Clinical Practice, 70(12), 966. doi:10.1111/ijcp.12923
Citrome, L. (2016). Rosacea and dementia: Relative vs. absolute effect sizes. International Journal of Clinical Practice, 70(6), 428-429. doi:10.1111/ijcp.12834
Citrome, L. (2016). Schizophrenia relapse, patient considerations, and potential role of lurasidone. Patient Preference and Adherence, 10, 1529-1537. doi:10.2147/PPA.S45401
Citrome, L. (2016). The grey literature is far from drab. International Journal of Clinical Practice, 70(10), 790. doi:10.1111/ijcp.12899
Citrome, L. (2016). Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Journal of Affective Disorders, 196, 225-233. doi:10.1016/j.jad.2016.02.042
Citrome, L. (2016). What's in a name? Use of brand vs. generic drug names. International Journal of Clinical Practice, 70(1), 3-4. doi:10.1111/ijcp.12772
Citrome, L. (2016). Which role for brexpiprazole, a new dopamine D2 partial agonist, in the treatment of schizophrenia? Evidence-Based Mental Health, 19(2), e6. doi:10.1136/eb-2015-102143
Citrome, L. (2016). Zika and you. International Journal of Clinical Practice, 70(3), 181-182. doi:10.1111/ijcp.12793
Citrome, L., & Ketter, T. A. (2013). When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. International Journal of Clinical Practice, 67(5), 407-411. doi:10.1111/ijcp.12142
